SEC EDGARNov 5$CHE

MCNAMARA KEVIN J sold $1.1M of CHE

MCNAMARA KEVIN J (president and CEO) sold 2,000 shares of CHEMED CORP (CHE) at $537.90 ($1.08M total) on 2026-11-03.

Original reporting

SEC EDGAR · MCNAMARA KEVIN J

Published Nov 5, 2026, 8:34 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Nov 5, 2026, 8:36 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefInsider activity

Primary signal

$CHE

Bearish

medium confidence

Mentioned

$CHE

Relevance

6/10

AlphAI data visualization · based on SEC EDGAR

Decision brief

The 30-second read

$CHEBearishLow

Why it matters

The CEO's sale reduces his ownership and may be interpreted as a lack of confidence, but could also be personal liquidity.

Market read

A modest insider sell that may cause slight short‑term pressure on CHE shares.

What to watch

Potential upcoming corporate actions or financing needs not disclosed.

Relevance 6/10Novelty 3/10Timing: post‑market filing

Background

Form 4 filings provide the first public disclosure of insider transactions.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$CHEBearishMedium confidence

Context

CEO Kevin J. McNamara sold 2,000 shares for $1.08M, reducing his stake to 82,220 shares.

Expected impact

likely modest pressure as the market prices in the insider sell.

Evidence & confidence

The sale is sizable for a micro‑cap and comes from the CEO, which can prompt short‑term selling pressure.

Market effects

Sector

Minimal impact on the broader chemical sector.

Regional

No significant regional effect.

Global

Limited to investors tracking insider activity.

Counterpoint

What could challenge this read

The sale could be a routine liquidity move, not a bearish signal.

Key entities

person
Kevin J. McNamara
President and CEO of Chemed Corp.
company
Chemed Corp.
Provider of health care services and products.

Read at source ← All news

$CHEMedAI 9/10

Chemed 3Q 2026: Revenue $690.9M, EPS $5.45— 10-Q Summary

Chemed reported Q3 2026 revenue of $690.9M, up 10.6% YoY, with net income rising 11.5% to $71.6M and EPS increasing 22.2% to $5.45. Growth in VITAS and Roto-Rooter segments drove results, while higher fuel costs pressured margins. The company acquired RotoCo and other franchises, expanding its territories.

tradingview.comOct 29

$CHEMed

What Chemed (CHE) Said on Its Q3 Earnings Call

Chemed reported Q3 earnings, with Roto-Rooter revenue up 7.5% but EBITDA down 2.5% due to higher costs. Commercial revenue grew 9% to $59.9M, while residential rose 5.2% to $158.8M. The company acquired California franchises for $62.5M, expecting $30M-$35M in 2027 revenue but less than $4M in EBITDA. Chemed repurchased 125,000 shares for $66M. Management expects 2026 EPS to meet or slightly exceed guidance.

finance.yahoo.comOct 29

$CHEHigh

Chemed Corp (CHE) Q3 2026 Earnings Call Highlights: VITAS Strength Drives 28% EPS Growth

Chemed Corp (CHE) reported Q3 2026 earnings with VITAS driving 28% EPS growth. Roto-Rooter saw a 2.5% EBITDA decline due to higher marketing and fuel costs. VITAS faces regulatory audits, reviewing $12-$14M in revenue. Chemed anticipates continued cost headwinds in Q4. Management discussed hiring, acquisitions, and lead generation strategies.

finance.yahoo.comOct 28

$CHEMed

Chemed outlines 12- to 18-month integration timeline for $62.5M California Roto-Rooter franchise buyback while expecting 2026 EPS at or slightly above prior high end (NYSE:CHE)

Chemed (CHE) announced a 12- to 18-month integration timeline for its $62.5M California Roto-Rooter franchise buyback. CEO Kevin McNamara reported VITAS revenue grew 12.2% year-over-year, driven by ADC growth and cost containment. The company expects 2026 EPS to be at or slightly above the prior high end.

seekingalpha.comOct 28

$CHEHighAI 8/10

Chemed (CHE) Q3 2026 Earnings Call Transcript

Chemed (CHE) reported Q3 2026 earnings with total revenue up 10.6% and adjusted EPS up 28.1% YoY. VITAS saw 12.2% revenue growth, while Roto Rooter grew 7.5%. Roto Rooter's margins declined due to higher marketing costs and fuel expenses, but acquisitions are expected to drive long-term growth. The company has $229M in cash flow from operations, enabling strategic acquisitions and share repurchases.